Skip to main content

Quidel Issues $172.5M of Senior Convertible Notes

NEW YORK(GenomeWeb) – Quidel said today in a regulatory document that it is issuing $172.5 million of its senior convertible notes. 

The issuance of the 3.25 percent senior notes due in 2020 is part of a deal between Quidel and the Bank of New York Mellon Trust. The notes will be senior unsecured obligations of Quidel, it said in a document filed with the US Securities and Exchange Commission. 

Quidel announced the public offering of $150 million in convertible senior notes last week. Net proceeds will go toward working capital and other general corporate purposes, which may include acquisitions of products, technologies, or businesses, and share repurchases.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.